The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
Open accessAbstract
BACKGROUND & AIMS: The aim of this study was to provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040. METHODS: Estimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020. Age-standardized incidence and mortality rates were calculated overall, by sex, histologic subtype (adenocarcinoma [AC] and squamous cell carcinoma [SCC]), country, and level of human development for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections. RESULTS: Globally, there were an estimated 604,100 new cases of, and 544,100 deaths from, esophageal cancer in 2020, corresponding to age-standardized incidence and mortality rates of 6.3 and 5.6 per 100,000, respectively. Most cases were SCCs (85% [512,500 cases]) and 14% (85,700 cases) were ACs. Incidence and mortality rates were 2- to 3-fold higher in male (9.3 and 8.2, respectively) compared with female (3.6 and 3.2, respectively) individuals. Global variations in incidence and mortality were observed across countries and world regions; the highest rates occurred in Eastern Asia and Southern and Eastern Africa and the lowest occurred in Western Africa and Central America regions. If rates remain stable, 957,000 new cases (141,300 AC cases and 806,000 SCC cases) and 880,000 deaths from esophageal cancer are expected in 2040. CONCLUSIONS: These updated estimates of the global burden of esophageal cancer represent an important baseline for setting priorities in policy making and developing and accelerating cancer control initiatives to reduce the current and projected burden. Although primary prevention remains key, screening and early detection represent important components of esophageal cancer control in high-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Self-citationEstimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Self-citationRustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
Arnold, M., Rutherford, M. J., Bardot, A., Ferlay, J., Andersson, T. M.-L., Myklebust, T. Å., Tervonen, H., Thursfield, V., Ransom, D., Shack, L., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30456-5 · Cited by 1,063
Self-citationCancer mortality for selected sites in 24 countries
栗原, 登., & 瀬木, 三. (1960) · Medical Entomology and Zoology · Cited by 871
Rare cancers are not so rare: The rare cancer burden in Europe
Gatta, G., van der Zwan, J. M., Casali, P. G., Siesling, S., Dei Tos, A. P., Kunkler, I., Otter, R., Licitra, L., Mallone, S., Tavilla, A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.08.008 · Cited by 809
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
Arnold, M., Ferlay, J., van Berge Henegouwen, M. I., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2020-321600 · Cited by 599
Self-citationThe Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Self-citationArnold, M., Laversanne, M., Brown, L. M., Devesa, S. S., & Bray, F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.155 · Cited by 465
Self-citationWei, W.-Q., Chen, Z.-F., He, Y.-T., Feng, H., Hou, J., Lin, D.-M., Li, X.-Q., Guo, C.-L., Li, S.-S., Wang, G.-Q., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0423 · Cited by 329
Cancer incidence in five continents : a technical report
Doll, R., Payne, P. M., & Waterhouse, J. A. H. (1966) · Springer eBooks · Cited by 319
Fitzgerald, R. C., di Pietro, M., O'Donovan, M., Maroni, R., Muldrew, B., Debiram-Beecham, I., Gehrung, M., Offman, J., Tripathi, M., Smith, S. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31099-0 · Cited by 261
Moehler, M., Shitara, K., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., Liu, T., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2296 · Cited by 208
Sheikh, M., Poustchi, H., Pourshams, A., Etemadi, A., Islami, F., Khoshnia, M., Gharavi, A., Hashemian, M., Roshandel, G., Khademi, H., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.024 · Cited by 177
Screening for oesophageal cancer
Lao-Sirieix, P., & Fitzgerald, R. C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.35 · Cited by 159
El‐Serag, H. B., Hashmi, A., Garcia, J. M., Richardson, P., Alsarraj, A., Fitzgerald, S. J., Vela, M. F., Shaib, Y. H., Abraham, N. S., Velez, M. E., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304189 · Cited by 152
Menya, D., Maina, S. K., Kibosia, C., Kigen, N., Oduor, M., Some, F. F., Chumba, D., Ayuo, P. O., Middleton, D. R. S., Osano, O., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32086 · Cited by 94
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014
Morgan, E., Soerjomataram, I., Gavin, A., Rutherford, M. J., Gatenby, P. A. C., Bardot, A., Ferlay, J., Bucher, O., De, P., Engholm, G., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321089 · Cited by 88
Self-citationThe African Esophageal Cancer Consortium: A Call to Action
Loon, K. V., Mwachiro, M., Abnet, C. C., Akoko, L., Assefa, M., Burgert, S. L., Chasimpha, S., Dzamalala, C. P., Fleischer, D. E., Gopal, S., et al. (2018) · Journal of Global Oncology · doi:10.1200/jgo.17.00163 · Cited by 82
Middleton, D. R. S., Menya, D., Kigen, N., Oduor, M., Maina, S. K., Some, F. F., Chumba, D., Ayuo, P. O., Osano, O., Schüz, J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32032 · Cited by 71
International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence
Rumgay, H., Arnold, M., Laversanne, M., Whiteman, D. C., Thrift, A. P., Wei, W., Lemmens, V. E. P. P., & Soerjomataram, I. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001121 · Cited by 71
Self-citationCancer Incidence in Five Continents. Cumulative rate and cumulative risk.
Day, N. E. (1992) · PubMed · Cited by 41
Semnani, S. H., Besharat, S., Abdolahi, N., Kalavi, K., Fazeli, S. A., Davarian, A., Danesh, A., & Malekzadeh, R. (2005) · PubMed · Cited by 24
Cited by
Zhou, J., Xu, Y., Liu, J., Feng, L., Yu, J., & Chen, D. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102693 · Cited by 389
Yang, H., Wang, F., Hallemeier, C. L., Lerut, T., & Fu, J. (2024) · The Lancet · doi:10.1016/s0140-6736(24)02226-8 · Cited by 299
Current Status and Future Prospects for Esophageal Cancer
Sheikh, M., Roshandel, G., McCormack, V., & Malekzadeh, R. (2023) · Cancers · doi:10.3390/cancers15030765 · Cited by 270
Li, J., Li, L., You, P., Wei, Y., & Xu, B. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.009 · Cited by 55
Global trends in esophageal cancer mortality with predictions to 2025, and in incidence by histotype
Santucci, C., Mignozzi, S., Malvezzi, M., Collatuzzo, G., Levi, F., La Vecchia, C., & Negri, E. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102486 · Cited by 42
Metadata
- Authors
- Morgan, E., Soerjomataram, I., Rumgay, H., Coleman, H. G., Thrift, A. P., Vignat, J., Laversanne, M., Ferlay, J., & Arnold, M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 163
- Issue
- 3
- Pages
- 649-658.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W4281669451
- Cited by
- 1,199
- References
- 27
- FWCI
- 197.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.